2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine.

[1]  B. Shaz,et al.  Zika Virus and the Blood Supply: What Do We Know? , 2017, Transfusion medicine reviews.

[2]  L. Rodrigues,et al.  Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. , 2016, The Lancet. Infectious diseases.

[3]  X. de Lamballerie,et al.  Long-Lasting Persistence of Zika Virus in Semen. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Q. S. Huang,et al.  Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016 , 2016, Emerging infectious diseases.

[5]  Ruili Huang,et al.  Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen , 2016, Nature Medicine.

[6]  Maria Teresa Dell'Anno,et al.  Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia. , 2016, Cell reports.

[7]  J. Sejvar,et al.  Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[8]  R. Lanciotti,et al.  Pathology of congenital Zika syndrome in Brazil: a case series , 2016, The Lancet.

[9]  Nikos Vasilakis,et al.  A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection. , 2016, Cell host & microbe.

[10]  Carolina Q. Sacramento,et al.  The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication , 2016, bioRxiv.

[11]  M. Diamond,et al.  Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise , 2016, Cell.

[12]  M. Busch,et al.  Zika virus: a new challenge for blood transfusion , 2016, The Lancet.

[13]  M. Diamond,et al.  A Mouse Model of Zika Virus Pathogenesis. , 2016, Cell host & microbe.

[14]  P. Garcez,et al.  Chloroquine inhibits Zika Virus infection in different cellular models , 2016, bioRxiv.

[15]  F. Kashanchi,et al.  Zika Virus: A New Animal Model for an Arbovirus , 2016, PLoS neglected tropical diseases.

[16]  J. Neyts,et al.  The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model , 2016, bioRxiv.

[17]  J. Brooks,et al.  Male-to-Male Sexual Transmission of Zika Virus--Texas, January 2016. , 2016, MMWR. Morbidity and mortality weekly report.

[18]  Eric D'Ortenzio,et al.  Evidence of Sexual Transmission of Zika Virus. , 2016, The New England journal of medicine.

[19]  S. Rasmussen,et al.  Zika Virus and Birth Defects--Reviewing the Evidence for Causality. , 2016, The New England journal of medicine.

[20]  A. Act,et al.  Zika Virus Infection in Pregnant Women in Rio de Janeiro - Preliminary Report. , 2016 .

[21]  Graham Hall,et al.  A Susceptible Mouse Model for Zika Virus Infection , 2016, bioRxiv.

[22]  Sen Chen,et al.  Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway. , 2016, Biochemical and biophysical research communications.

[23]  L. Schuler‐Faccini,et al.  Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. , 2016, MMWR. Morbidity and mortality weekly report.

[24]  E. Laurini,et al.  Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. , 2015, European journal of medicinal chemistry.

[25]  S. Vesenbeckh,et al.  Mefloquine as a potential drug against multidrug-resistant tuberculosis , 2015, European Respiratory Journal.

[26]  B. Lämmle,et al.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine , 2015, Journal of NeuroVirology.

[27]  D. Musso,et al.  Potential Sexual Transmission of Zika Virus , 2015, Emerging infectious diseases.

[28]  L. Bermudez,et al.  Mefloquine and Its Enantiomers Are Active against Mycobacterium tuberculosis In Vitro and in Macrophages , 2014, Tuberculosis research and treatment.

[29]  Peter J. Smith,et al.  Synthesis of novel triazole-linked mefloquine derivatives: biological evaluation against Plasmodium falciparum. , 2014, Bioorganic & medicinal chemistry letters.

[30]  K. Chu,et al.  Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy , 2014, Journal of Clinical Neuroscience.

[31]  Yogesh Kumar,et al.  Progressive Multifocal Leukoencephalopathy in a 62-Year-Old Immunocompetent Woman , 2014, Case reports in neurological medicine.

[32]  B. Cavalcanti,et al.  Mefloquine–Oxazolidine Derivatives: A New Class of Anticancer Agents , 2014, Chemical biology & drug design.

[33]  S. Chuang,et al.  Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo , 2013, Oncology letters.

[34]  T. Yamawaki,et al.  Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. , 2012, Internal medicine.

[35]  C. Kaiser,et al.  Mefloquine-oxazolidine derivatives, derived from mefloquine and arenecarbaldehydes: In vitro activity including against the multidrug-resistant tuberculosis strain T113. , 2012, Bioorganic & medicinal chemistry.

[36]  B. Poojary,et al.  Synthesis and antimicrobial activity of 1,2,3-triazoles containing quinoline moiety , 2010, Archives of pharmacal research.

[37]  A. V. Adhikari,et al.  New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties. , 2010, European journal of medicinal chemistry.

[38]  K. Simon,et al.  Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro , 2009, Antimicrobial Agents and Chemotherapy.

[39]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[40]  A. Kozikowski,et al.  Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents , 2006, ChemMedChem.

[41]  N. White,et al.  Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. , 2004, Acta tropica.

[42]  J. Wachira,et al.  Cytotoxicity of novel trifluoromethylquinoline derivatives on human leukemia cells. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[44]  G. Dick,et al.  Zika virus. I. Isolations and serological specificity. , 1952, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[45]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .